Compare ENTA & OPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENTA | OPRT |
|---|---|---|
| Founded | 1995 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 377.5M | 421.7M |
| IPO Year | 2012 | 2019 |
| Metric | ENTA | OPRT |
|---|---|---|
| Price | $11.37 | $8.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $21.83 | $11.50 |
| AVG Volume (30 Days) | 242.2K | ★ 704.4K |
| Earning Date | 11-16-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.93 | ★ 127.18 |
| EPS | N/A | ★ 0.22 |
| Revenue | $102,814,000.00 | ★ $956,685,000.00 |
| Revenue This Year | N/A | $30.33 |
| Revenue Next Year | N/A | $5.23 |
| P/E Ratio | ★ N/A | $41.20 |
| Revenue Growth | ★ 16.48 | N/A |
| 52 Week Low | $10.20 | $4.03 |
| 52 Week High | $17.15 | $9.35 |
| Indicator | ENTA | OPRT |
|---|---|---|
| Relative Strength Index (RSI) | 43.19 | 59.80 |
| Support Level | $10.86 | $7.12 |
| Resistance Level | $13.95 | N/A |
| Average True Range (ATR) | 0.64 | 0.36 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 28.14 | 68.38 |
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.